Amy Stark to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications Amy Stark has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.137
-
The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide. Mol Cancer Ther. 2014 May; 13(5):1334-44.
Score: 0.110
-
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients. Clin Pharmacol Ther. 2014 Jun; 95(6):644-52.
Score: 0.027